Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement

To combat infectious diseases, vaccines are considered the best prophylactic strategy for a wide range of the population, but even when vaccines are effective, the administration of therapeutic antibodies against viruses could provide further treatment options, particularly for vulnerable groups who...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampei, Zenjiro, Koo, Christine Xing’er, Teo, Frannie Jiuyi, Toh, Ying Xiu, Fukuzawa, Taku, Gan, Siok Wan, Nambu, Takeru, Ho, Adrian, Honda, Kiyofumi, Igawa, Tomoyuki, Ahmed, Fariyal, Wang, Cheng-I, Fink, Katja, Nezu, Junichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204484/
https://www.ncbi.nlm.nih.gov/pubmed/37218902
http://dx.doi.org/10.3390/antib12020036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204484/
https://www.ncbi.nlm.nih.gov/pubmed/37218902
http://dx.doi.org/10.3390/antib12020036

Ejemplares similares